Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris
Public ClinicalTrials.gov record NCT03003247. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle- Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris
Study identification
- NCT ID
- NCT03003247
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 364 participants
Conditions and interventions
Conditions
Interventions
- IDP-120 Gel Drug
- IDP 120 Component A Gel Drug
- IDP 120 Component B Gel Drug
- IDP 120 Vehicle Gel Drug
Drug
Eligibility (public fields only)
- Age range
- 9 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2015 (Actual)
- Primary completion
- Aug 31, 2016 (Actual)
- Completion
- Sep 30, 2016 (Actual)
- Last update posted
- Dec 18, 2017
2015 – 2016
United States locations
- U.S. sites
- 20
- U.S. states
- 13
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valeant Site 15 | Encino | California | 91316 | — |
| Valeant Site 13 | Lake Mary | Florida | 32746 | — |
| Valeant Site 16 | Miami | Florida | 33101 | — |
| Valeant Site 14 | Tampa | Florida | 33601 | — |
| Valeant Site 02 | West Palm Beach | Florida | 33401 | — |
| Valeant Site 21 | Atlanta | Georgia | 30302 | — |
| Valeant Site 23 | South Bend | Indiana | 46601 | — |
| Valeant Site 09 | Detroit | Michigan | 48204 | — |
| Valeant Site 24 | Minneapolis | Minnesota | 55401 | — |
| Valeant Site 11 | Saint Joseph | Missouri | 64502 | — |
| Valreant Site 05 | New York | New York | 10001 | — |
| Valeant Site 06 | New York | New York | 10002 | — |
| Valeant Site 01 | Chapel Hill | North Carolina | 27517 | — |
| Valeant Site 17 | High Point | North Carolina | 27268 | — |
| Valeant Site 22 | Columbus | Ohio | 43085 | — |
| Valeant Site 04 | Knoxville | Tennessee | 37901 | — |
| Valeant Site 07 | Austin | Texas | 73301 | — |
| Valeant Site 12 | Austin | Texas | 78701 | — |
| Valeant Site 18 | San Antonio | Texas | 78204 | — |
| Valeant Site 25 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03003247, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 18, 2017 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03003247 live on ClinicalTrials.gov.